These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

50 related items for PubMed ID: 2519902

  • 1. Dietary salt, blood pressure and circulating levels of 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine in patients with essential hypertension.
    Masugi F, Sakaguchi K, Saeki S, Imaoka M, Ogihara T.
    J Lipid Mediat; 1989; 1(6):341-8. PubMed ID: 2519902
    [Abstract] [Full Text] [Related]

  • 2. Studies on the role of platelet-activating factor in blood pressure regulation.
    Sakaguchi K, Morimoto S, Masugi F, Saeki S, Ogihara T, Yamada K, Yamatsu I.
    Lipids; 1991 Dec; 26(12):1264-8. PubMed ID: 1840277
    [Abstract] [Full Text] [Related]

  • 3. Radiation-induced increased platelet-activating factor activity in mixed saliva.
    McManus LM, Ostrom KK, Lear C, Luce EB, Gander DL, Pinckard RN, Redding SW.
    Lab Invest; 1993 Jan; 68(1):118-24. PubMed ID: 8423671
    [Abstract] [Full Text] [Related]

  • 4. Species-specific variations in the molecular heterogeneity of the platelet-activating factor.
    Ramesha CS, Pickett WC.
    J Immunol; 1987 Mar 01; 138(5):1559-63. PubMed ID: 3100641
    [Abstract] [Full Text] [Related]

  • 5. Platelet-activating factor in human normal tears.
    Okumura N, Kojima K, Hashida M, Koura Y, Fukushima A, Ueno H.
    Curr Eye Res; 2005 Oct 01; 30(10):891-6. PubMed ID: 16251126
    [Abstract] [Full Text] [Related]

  • 6. [Hormonal profile and participation of nitric oxide in salt-sensitive and salt-resistant essential arterial hypertension].
    Gómez-Fernández P, Moreno VG, Cornejo M, Vargas JC, García-Barroso C, Velasco G, Almaraz M.
    Nefrologia; 2000 Oct 01; 20(5):415-23. PubMed ID: 11100662
    [Abstract] [Full Text] [Related]

  • 7. The influence of salt intake on plasma calcitonin gene-related peptide in subjects with mild essential hypertension.
    Zoccali C, Mallamaci F, Parlongo S.
    J Hypertens; 1994 Nov 01; 12(11):1249-53. PubMed ID: 7868872
    [Abstract] [Full Text] [Related]

  • 8. Quantitative analysis of platelet activating factor treated with pentafluorobenzoyl chloride using gas chromatography/negative ion chemical ionization mass spectrometry.
    Shindo K, Hashimoto Y.
    Drugs Exp Clin Res; 1991 Nov 01; 17(7):343-9. PubMed ID: 1794300
    [Abstract] [Full Text] [Related]

  • 9. Cardiopulmonary and intravascular alterations during the sustained infusion of PAF.
    Deavers SI, Arroyave JM, Prihoda TJ, McManus LM.
    J Lipid Mediat; 1991 Nov 01; 4(2):145-63. PubMed ID: 1954334
    [Abstract] [Full Text] [Related]

  • 10. Changes in plasma lipids and uric acid with sodium loading and sodium depletion in patients with essential hypertension.
    Masugi F, Ogihara T, Hashizume K, Hasegawa T, Sakaguchi K, Kumahara Y.
    J Hum Hypertens; 1988 Mar 01; 1(4):293-8. PubMed ID: 3221377
    [Abstract] [Full Text] [Related]

  • 11. Circulatory volume in essential hypertension. Relationships with age, blood pressure, exchangeable sodium, renin, aldosterone and catecholamines.
    Beretta-Piccoli C, Weidmann P.
    Miner Electrolyte Metab; 1984 Mar 01; 10(5):292-300. PubMed ID: 6387428
    [Abstract] [Full Text] [Related]

  • 12. Cardiac output and peripheral vascular resistance during intravenous infusion of 1-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine in conscious normotensive and spontaneously hypertensive rats.
    Hubbard JW, Cox RH, Lawler JE, Blank ML, Snyder F.
    Res Commun Chem Pathol Pharmacol; 1985 Sep 01; 49(3):459-62. PubMed ID: 4059660
    [Abstract] [Full Text] [Related]

  • 13. Body sodium blood volume state in essential hypertension: abnormal relation of exchangeable sodium to age and blood pressure in male patients.
    Beretta-Piccoli C, Weidmann P, Brown JJ, Davies DL, Lever AF, Robertson JI.
    J Cardiovasc Pharmacol; 1984 Sep 01; 6 Suppl 1():S134-42. PubMed ID: 6204132
    [Abstract] [Full Text] [Related]

  • 14. Intracellular ionic consequences of dietary salt loading in essential hypertension. Relation to blood pressure and effects of calcium channel blockade.
    Resnick LM, Gupta RK, DiFabio B, Barbagallo M, Mann S, Marion R, Laragh JH.
    J Clin Invest; 1994 Sep 01; 94(3):1269-76. PubMed ID: 8083368
    [Abstract] [Full Text] [Related]

  • 15. Age is a major determinant of the divergent blood pressure responses to varying salt intake in essential hypertension.
    Overlack A, Ruppert M, Kolloch R, Kraft K, Stumpe KO.
    Am J Hypertens; 1995 Aug 01; 8(8):829-36. PubMed ID: 7576400
    [Abstract] [Full Text] [Related]

  • 16. [Binding of 1-0-alkyl-2-0-acetyl-sn-glycero-3-phosphocholine (thrombocyte activating factor) by plasma components. Exchange of the thrombocyte activating factor between lipoproteins and thrombocytes].
    Kulikov VI, Bergel'son LD.
    Biokhimiia; 1984 Aug 01; 49(8):1310-5. PubMed ID: 6093897
    [Abstract] [Full Text] [Related]

  • 17. Lifestyle modifications to prevent and control hypertension. 5. Recommendations on dietary salt. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Fodor JG, Whitmore B, Leenen F, Larochelle P.
    CMAJ; 1999 May 04; 160(9 Suppl):S29-34. PubMed ID: 10333851
    [Abstract] [Full Text] [Related]

  • 18. Molecular species of platelet-activating factor generated by human neutrophils challenged with ionophore A23187.
    Oda M, Satouchi K, Yasunaga K, Saito K.
    J Immunol; 1985 Feb 04; 134(2):1090-3. PubMed ID: 3917470
    [Abstract] [Full Text] [Related]

  • 19. Increase in plasma ouabainlike inhibitor of Na+, K+-ATPase with high sodium intake in patients with essential hypertension.
    Hasegawa T, Masugi F, Ogihara T, Kumahara Y.
    J Clin Hypertens; 1987 Dec 04; 3(4):419-29. PubMed ID: 2839625
    [Abstract] [Full Text] [Related]

  • 20. Effect of salt intake on endothelium-derived factors in a group of patients with essential hypertension.
    Bragulat E, de la Sierra A, Antonio MT, Jiménez W, Urbano-Márquez A, Coca A.
    Clin Sci (Lond); 2001 Jul 04; 101(1):73-8. PubMed ID: 11410117
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.